Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hbp1
|
ENSMUSG00000002996.11 | high mobility group box transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_31984970_31985121 | Hbp1 | 34510 | 0.151684 | -0.22 | 9.5e-02 | Click! |
chr12_31943610_31943761 | Hbp1 | 3278 | 0.249194 | -0.17 | 1.9e-01 | Click! |
chr12_31948971_31949430 | Hbp1 | 408 | 0.855931 | 0.12 | 3.7e-01 | Click! |
chr12_31950673_31951144 | Hbp1 | 373 | 0.874257 | -0.11 | 4.0e-01 | Click! |
chr12_31943824_31944025 | Hbp1 | 3517 | 0.242000 | 0.10 | 4.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_94995811_94996872 | 18.42 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
680 |
0.57 |
chr7_51629095_51630495 | 16.53 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
315 |
0.88 |
chr11_41999400_42000640 | 15.51 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr7_51623529_51624502 | 14.02 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1133 |
0.51 |
chr3_88206822_88208169 | 13.44 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr1_115686481_115687365 | 13.23 |
Cntnap5a |
contactin associated protein-like 5A |
2167 |
0.34 |
chr4_22484307_22484937 | 12.91 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
3744 |
0.2 |
chr10_34299043_34301066 | 12.67 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr12_72234504_72235243 | 11.61 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr1_177446374_177448525 | 11.26 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr12_29529828_29531185 | 11.10 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr13_83737592_83739114 | 10.91 |
Gm33366 |
predicted gene, 33366 |
182 |
0.66 |
chr9_58197310_58202560 | 10.71 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr13_34126566_34127191 | 10.02 |
Tubb2b |
tubulin, beta 2B class IIB |
3476 |
0.13 |
chr2_21367263_21369086 | 9.93 |
Gpr158 |
G protein-coupled receptor 158 |
607 |
0.59 |
chr10_21883302_21884037 | 9.74 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
1300 |
0.42 |
chr10_64088546_64089368 | 9.68 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
1290 |
0.62 |
chr5_103209022_103210413 | 9.54 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr8_54954519_54955779 | 9.49 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr2_6881874_6882908 | 9.46 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr16_77418527_77418853 | 9.39 |
Gm38071 |
predicted gene, 38071 |
2066 |
0.19 |
chr2_65932868_65933620 | 9.35 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
1379 |
0.47 |
chr5_97222612_97223731 | 9.26 |
Gm2861 |
predicted gene 2861 |
27585 |
0.16 |
chr3_4796861_4798079 | 9.21 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
88 |
0.98 |
chr17_93198991_93201483 | 9.19 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr16_77418973_77419718 | 9.01 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
2475 |
0.17 |
chr7_131968073_131968591 | 8.83 |
Gpr26 |
G protein-coupled receptor 26 |
1872 |
0.37 |
chr14_66344363_66345813 | 8.82 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr13_8205494_8206737 | 8.73 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
3193 |
0.23 |
chrX_110809955_110811467 | 8.50 |
Gm44593 |
predicted gene 44593 |
1613 |
0.43 |
chr16_81202167_81203211 | 8.43 |
Ncam2 |
neural cell adhesion molecule 2 |
1932 |
0.44 |
chr3_146768414_146769205 | 8.34 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
1452 |
0.4 |
chr10_36509078_36510052 | 8.30 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
2158 |
0.44 |
chr13_83742301_83742867 | 8.29 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3721 |
0.15 |
chr8_41052368_41053980 | 8.21 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chr6_83185720_83187846 | 8.20 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr1_66177799_66178086 | 8.20 |
Map2 |
microtubule-associated protein 2 |
2392 |
0.38 |
chr2_6883618_6884699 | 8.09 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr12_41483283_41485192 | 8.01 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chrX_166347339_166348040 | 7.92 |
Gpm6b |
glycoprotein m6b |
2847 |
0.32 |
chr5_30106299_30106676 | 7.84 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
401 |
0.71 |
chr9_110051810_110053856 | 7.83 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr13_99510773_99511921 | 7.76 |
Map1b |
microtubule-associated protein 1B |
5171 |
0.17 |
chr9_91366433_91367646 | 7.71 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1229 |
0.26 |
chr13_83741336_83742027 | 7.68 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2818 |
0.16 |
chr2_181313043_181314281 | 7.66 |
Stmn3 |
stathmin-like 3 |
838 |
0.42 |
chr7_31049379_31049672 | 7.64 |
Fxyd7 |
FXYD domain-containing ion transport regulator 7 |
1878 |
0.15 |
chrX_152643367_152644550 | 7.60 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr8_70119024_70120981 | 7.57 |
Ncan |
neurocan |
871 |
0.35 |
chr14_65423052_65425451 | 7.56 |
Pnoc |
prepronociceptin |
909 |
0.6 |
chr1_42700192_42700666 | 7.56 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
4661 |
0.15 |
chr1_66323058_66323271 | 7.49 |
Map2 |
microtubule-associated protein 2 |
1062 |
0.51 |
chr1_72533122_72533871 | 7.47 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
3434 |
0.27 |
chrX_133684830_133685971 | 7.44 |
Pcdh19 |
protocadherin 19 |
409 |
0.91 |
chr13_83732205_83734272 | 7.43 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr6_17750183_17750783 | 7.41 |
St7 |
suppression of tumorigenicity 7 |
1091 |
0.38 |
chr9_4793875_4794307 | 7.41 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
1428 |
0.59 |
chr5_112225574_112226319 | 7.40 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
2695 |
0.17 |
chr1_160350716_160351791 | 7.36 |
Rabgap1l |
RAB GTPase activating protein 1-like |
318 |
0.88 |
chr4_110290101_110291006 | 7.27 |
Elavl4 |
ELAV like RNA binding protein 4 |
281 |
0.95 |
chr13_20474586_20474920 | 7.27 |
Gm32036 |
predicted gene, 32036 |
1263 |
0.38 |
chr8_14384517_14385115 | 7.24 |
Dlgap2 |
DLG associated protein 2 |
2820 |
0.33 |
chr15_30458403_30458947 | 7.24 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
887 |
0.67 |
chr9_43069907_43070263 | 7.21 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
27453 |
0.17 |
chr2_97468266_97469202 | 7.21 |
Lrrc4c |
leucine rich repeat containing 4C |
645 |
0.83 |
chr5_84413029_84413589 | 7.21 |
Epha5 |
Eph receptor A5 |
3497 |
0.31 |
chr12_46816152_46816702 | 7.17 |
Nova1 |
NOVA alternative splicing regulator 1 |
533 |
0.8 |
chr5_131532921_131534054 | 7.15 |
Auts2 |
autism susceptibility candidate 2 |
910 |
0.58 |
chr7_126823319_126824529 | 7.13 |
Fam57b |
family with sequence similarity 57, member B |
621 |
0.41 |
chr1_81079064_81079824 | 7.13 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
1861 |
0.49 |
chr7_128689234_128689975 | 7.10 |
Gm43580 |
predicted gene 43580 |
1069 |
0.26 |
chr14_39469812_39470401 | 7.10 |
Nrg3 |
neuregulin 3 |
2560 |
0.44 |
chr6_104492794_104494036 | 7.03 |
Cntn6 |
contactin 6 |
167 |
0.98 |
chr14_64592253_64592626 | 7.00 |
Mir3078 |
microRNA 3078 |
1254 |
0.34 |
chr13_109442519_109443753 | 6.95 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chr15_95525022_95525792 | 6.93 |
Nell2 |
NEL-like 2 |
2771 |
0.35 |
chr3_8512495_8512918 | 6.93 |
Stmn2 |
stathmin-like 2 |
3120 |
0.28 |
chr12_29535679_29535830 | 6.91 |
Myt1l |
myelin transcription factor 1-like |
532 |
0.63 |
chr6_103512786_103513033 | 6.90 |
Chl1 |
cell adhesion molecule L1-like |
1579 |
0.36 |
chr15_72805381_72805998 | 6.85 |
Peg13 |
paternally expressed 13 |
4635 |
0.28 |
chr7_46399823_46400899 | 6.75 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
2713 |
0.23 |
chr1_99774053_99774267 | 6.72 |
Cntnap5b |
contactin associated protein-like 5B |
1395 |
0.49 |
chr15_25753053_25753722 | 6.72 |
Myo10 |
myosin X |
408 |
0.88 |
chr1_194623571_194625393 | 6.71 |
Plxna2 |
plexin A2 |
4657 |
0.21 |
chr1_136132801_136134260 | 6.71 |
Kif21b |
kinesin family member 21B |
2076 |
0.19 |
chr9_112232067_112232798 | 6.69 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
69 |
0.97 |
chr4_49843344_49843495 | 6.68 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
2130 |
0.42 |
chr1_42691569_42692627 | 6.68 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
995 |
0.42 |
chr15_25415436_25415919 | 6.64 |
Gm48957 |
predicted gene, 48957 |
614 |
0.58 |
chr6_13834624_13835191 | 6.58 |
Gpr85 |
G protein-coupled receptor 85 |
2334 |
0.31 |
chr10_81229656_81230911 | 6.56 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr1_66386919_66387899 | 6.54 |
Map2 |
microtubule-associated protein 2 |
398 |
0.87 |
chr1_115684558_115685809 | 6.50 |
Cntnap5a |
contactin associated protein-like 5A |
427 |
0.58 |
chr1_66323360_66324079 | 6.49 |
Map2 |
microtubule-associated protein 2 |
1617 |
0.37 |
chr1_143641893_143642230 | 6.48 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
464 |
0.75 |
chr17_43952337_43954220 | 6.48 |
Rcan2 |
regulator of calcineurin 2 |
27 |
0.99 |
chr2_22627938_22628458 | 6.45 |
Gad2 |
glutamic acid decarboxylase 2 |
4894 |
0.15 |
chrX_66655351_66656679 | 6.45 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
3008 |
0.24 |
chr8_109248088_109248728 | 6.45 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1458 |
0.54 |
chr1_42701809_42702229 | 6.33 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
6033 |
0.14 |
chr1_81077232_81078427 | 6.30 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr8_54956899_54957247 | 6.29 |
Gpm6a |
glycoprotein m6a |
2230 |
0.24 |
chr3_31309063_31309219 | 6.28 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
1237 |
0.41 |
chr17_78508180_78509392 | 6.26 |
Vit |
vitrin |
614 |
0.7 |
chr6_116055030_116055442 | 6.24 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
1719 |
0.34 |
chr1_143640264_143641520 | 6.23 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
228 |
0.59 |
chr13_56894622_56895022 | 6.23 |
Trpc7 |
transient receptor potential cation channel, subfamily C, member 7 |
915 |
0.67 |
chr5_115908055_115909691 | 6.22 |
Cit |
citron |
1403 |
0.37 |
chr13_83723698_83723849 | 6.21 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2392 |
0.2 |
chr17_90452047_90452824 | 6.21 |
Nrxn1 |
neurexin I |
2387 |
0.31 |
chr1_173389412_173390669 | 6.20 |
Cadm3 |
cell adhesion molecule 3 |
22345 |
0.14 |
chrX_9202282_9203095 | 6.20 |
Lancl3 |
LanC lantibiotic synthetase component C-like 3 (bacterial) |
2786 |
0.21 |
chr8_106336310_106337932 | 6.17 |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral |
867 |
0.61 |
chr2_65620767_65621991 | 6.14 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr2_74734325_74737080 | 6.11 |
Hoxd3 |
homeobox D3 |
813 |
0.31 |
chr2_28195247_28196182 | 6.10 |
Olfm1 |
olfactomedin 1 |
2621 |
0.32 |
chr10_86490806_86491632 | 6.09 |
Syn3 |
synapsin III |
678 |
0.59 |
chr4_22483631_22483884 | 6.08 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
4609 |
0.19 |
chr4_109342938_109343450 | 6.06 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
59 |
0.97 |
chrX_143930842_143933141 | 6.04 |
Dcx |
doublecortin |
1059 |
0.64 |
chr14_100374663_100375528 | 6.02 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr19_32102301_32103300 | 6.02 |
Asah2 |
N-acylsphingosine amidohydrolase 2 |
324 |
0.92 |
chr13_83717521_83718816 | 6.01 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr1_66321652_66322390 | 5.99 |
Map2 |
microtubule-associated protein 2 |
23 |
0.98 |
chr7_44592789_44594513 | 5.99 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
344 |
0.69 |
chr7_19175632_19177533 | 5.95 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chr8_35592634_35593539 | 5.95 |
Gm16793 |
predicted gene, 16793 |
4114 |
0.21 |
chrX_6169933_6171264 | 5.93 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
2417 |
0.31 |
chr13_78193022_78193812 | 5.90 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
2956 |
0.18 |
chr7_99272446_99273539 | 5.86 |
Map6 |
microtubule-associated protein 6 |
3860 |
0.15 |
chr13_83728524_83729044 | 5.83 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
678 |
0.43 |
chr4_13752540_13753163 | 5.82 |
Runx1t1 |
RUNX1 translocation partner 1 |
1554 |
0.54 |
chr9_4793004_4793465 | 5.81 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
2285 |
0.46 |
chr10_110453550_110454045 | 5.77 |
Nav3 |
neuron navigator 3 |
2407 |
0.34 |
chr5_71093034_71093402 | 5.75 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
1422 |
0.6 |
chr15_78116860_78117881 | 5.73 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
2336 |
0.22 |
chr3_133614015_133615285 | 5.73 |
Gm37228 |
predicted gene, 37228 |
20108 |
0.15 |
chr8_123891512_123893657 | 5.72 |
Acta1 |
actin, alpha 1, skeletal muscle |
2167 |
0.16 |
chr8_109245493_109246323 | 5.72 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr15_18820164_18820708 | 5.72 |
Cdh10 |
cadherin 10 |
107 |
0.96 |
chr10_73821409_73822534 | 5.71 |
Pcdh15 |
protocadherin 15 |
28 |
0.99 |
chr7_87586513_87587584 | 5.70 |
Grm5 |
glutamate receptor, metabotropic 5 |
2650 |
0.4 |
chr3_108153841_108154889 | 5.68 |
Gpr61 |
G protein-coupled receptor 61 |
517 |
0.6 |
chr9_106147912_106149765 | 5.67 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr2_181715341_181715994 | 5.67 |
Oprl1 |
opioid receptor-like 1 |
35 |
0.95 |
chr1_135579927_135581701 | 5.64 |
Gm4793 |
predicted gene 4793 |
3959 |
0.2 |
chr7_128690432_128691249 | 5.62 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr9_108824114_108825614 | 5.61 |
Gm35025 |
predicted gene, 35025 |
3 |
0.87 |
chr7_142091808_142093330 | 5.60 |
Dusp8 |
dual specificity phosphatase 8 |
2703 |
0.11 |
chr7_94042433_94043470 | 5.58 |
Gm32647 |
predicted gene, 32647 |
199 |
0.97 |
chr19_47017205_47017356 | 5.54 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2127 |
0.2 |
chr10_33621658_33622333 | 5.52 |
Gm47911 |
predicted gene, 47911 |
286 |
0.85 |
chr15_85675690_85676550 | 5.50 |
Lncppara |
long noncoding RNA near Ppara |
22504 |
0.12 |
chr14_25609557_25610191 | 5.49 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
2036 |
0.33 |
chr6_77977778_77977929 | 5.48 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
1697 |
0.41 |
chr5_114090407_114091746 | 5.48 |
Svop |
SV2 related protein |
291 |
0.84 |
chr4_42950234_42951162 | 5.47 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
258 |
0.87 |
chr2_65566312_65566743 | 5.43 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
965 |
0.63 |
chr10_49785211_49786117 | 5.43 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2255 |
0.25 |
chr5_88583326_88583955 | 5.43 |
Rufy3 |
RUN and FYVE domain containing 3 |
62 |
0.97 |
chr9_113813101_113813610 | 5.42 |
Clasp2 |
CLIP associating protein 2 |
755 |
0.71 |
chr3_45384939_45386122 | 5.42 |
Pcdh10 |
protocadherin 10 |
2897 |
0.22 |
chr4_82497680_82498758 | 5.41 |
Nfib |
nuclear factor I/B |
1097 |
0.54 |
chrX_57766985_57767599 | 5.40 |
Gm14631 |
predicted gene 14631 |
13424 |
0.18 |
chr3_89092211_89093650 | 5.37 |
Rusc1 |
RUN and SH3 domain containing 1 |
360 |
0.7 |
chr12_67219520_67219941 | 5.36 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
1312 |
0.58 |
chr14_66865047_66865736 | 5.35 |
Dpysl2 |
dihydropyrimidinase-like 2 |
3297 |
0.19 |
chr3_76075976_76076354 | 5.33 |
Fstl5 |
follistatin-like 5 |
582 |
0.8 |
chr5_138275220_138276850 | 5.32 |
Gpc2 |
glypican 2 (cerebroglycan) |
2202 |
0.11 |
chr4_5724213_5725550 | 5.31 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr14_93888035_93888426 | 5.29 |
Pcdh9 |
protocadherin 9 |
502 |
0.87 |
chr10_84757399_84758243 | 5.27 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
1759 |
0.41 |
chr6_55680133_55680881 | 5.26 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chr3_17788652_17789129 | 5.26 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1031 |
0.53 |
chr3_97763340_97765161 | 5.24 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
3681 |
0.23 |
chr14_66347306_66348516 | 5.23 |
Stmn4 |
stathmin-like 4 |
3530 |
0.22 |
chr18_23036665_23037864 | 5.22 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr4_156183474_156184054 | 5.22 |
Agrn |
agrin |
2137 |
0.17 |
chr13_58809397_58810364 | 5.21 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
1189 |
0.34 |
chr15_91017138_91018295 | 5.20 |
Kif21a |
kinesin family member 21A |
32102 |
0.16 |
chrX_84076569_84077653 | 5.20 |
Dmd |
dystrophin, muscular dystrophy |
462 |
0.87 |
chr3_34197711_34199105 | 5.19 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1544 |
0.41 |
chr13_83735558_83735982 | 5.19 |
Gm33366 |
predicted gene, 33366 |
2765 |
0.16 |
chr18_43684790_43685423 | 5.16 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
2519 |
0.32 |
chrX_61116034_61117613 | 5.14 |
Cdr1os |
cerebellar degeneration related antigen 1, opposite strand |
425 |
0.47 |
chr3_34654574_34655689 | 5.14 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
905 |
0.42 |
chr6_136168799_136169205 | 5.13 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
2887 |
0.28 |
chr9_91369028_91370469 | 5.12 |
Zic4 |
zinc finger protein of the cerebellum 4 |
250 |
0.86 |
chr2_57613916_57615034 | 5.12 |
Gm13532 |
predicted gene 13532 |
14753 |
0.2 |
chr11_6604031_6604533 | 5.11 |
Nacad |
NAC alpha domain containing |
1771 |
0.17 |
chr8_73355545_73355705 | 5.11 |
Large1 |
LARGE xylosyl- and glucuronyltransferase 1 |
2085 |
0.44 |
chr16_39986224_39986375 | 5.11 |
Lsamp |
limbic system-associated membrane protein |
1704 |
0.49 |
chr7_99270744_99271357 | 5.11 |
Map6 |
microtubule-associated protein 6 |
1918 |
0.23 |
chr4_148284201_148285628 | 5.09 |
Disp3 |
dispatched RND transporter family member 3 |
3051 |
0.22 |
chrX_133682515_133683917 | 5.09 |
Pcdh19 |
protocadherin 19 |
1775 |
0.49 |
chr12_15811126_15812067 | 5.07 |
Trib2 |
tribbles pseudokinase 2 |
5189 |
0.17 |
chr10_110454344_110454630 | 5.05 |
Nav3 |
neuron navigator 3 |
1717 |
0.42 |
chr1_167608349_167608592 | 5.04 |
Rxrg |
retinoid X receptor gamma |
9839 |
0.27 |
chr6_55454267_55454889 | 5.02 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
2401 |
0.32 |
chr9_112232861_112233588 | 5.02 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
402 |
0.75 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 24.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
5.8 | 52.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
4.3 | 12.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
4.2 | 4.2 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
4.1 | 12.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
4.1 | 16.4 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.7 | 11.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.6 | 10.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
3.6 | 10.7 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
3.4 | 13.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.4 | 10.2 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.2 | 6.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
3.2 | 35.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
3.2 | 19.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
3.0 | 15.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
3.0 | 12.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
3.0 | 11.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.8 | 22.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.8 | 8.3 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.7 | 10.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.7 | 13.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.6 | 7.9 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
2.6 | 10.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.6 | 35.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
2.5 | 7.6 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.5 | 12.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.5 | 25.0 | GO:0071625 | vocalization behavior(GO:0071625) |
2.5 | 22.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
2.4 | 9.7 | GO:0061743 | motor learning(GO:0061743) |
2.4 | 31.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.4 | 16.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.4 | 16.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.4 | 14.1 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
2.4 | 14.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
2.3 | 7.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.3 | 13.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.2 | 6.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
2.2 | 8.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
2.2 | 4.3 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.0 | 6.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.0 | 5.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.0 | 9.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.9 | 5.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.9 | 5.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.8 | 16.3 | GO:0050957 | equilibrioception(GO:0050957) |
1.8 | 5.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.8 | 12.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.7 | 5.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.7 | 28.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.7 | 16.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.6 | 11.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.6 | 7.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.6 | 1.6 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
1.6 | 15.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.6 | 7.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.5 | 6.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.5 | 6.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.5 | 4.5 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.5 | 1.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.5 | 5.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.4 | 4.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.4 | 5.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.4 | 4.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.4 | 4.2 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.4 | 2.8 | GO:0048880 | sensory system development(GO:0048880) |
1.3 | 5.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.3 | 2.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.3 | 5.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.3 | 15.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.3 | 7.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.3 | 11.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.3 | 5.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.3 | 2.5 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.3 | 8.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.3 | 3.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.3 | 15.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.2 | 16.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.2 | 4.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.2 | 14.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.2 | 3.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.2 | 69.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.2 | 12.0 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
1.2 | 11.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
1.2 | 7.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.2 | 1.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.1 | 6.9 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.1 | 3.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.1 | 3.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.1 | 18.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 4.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.1 | 5.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.1 | 3.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.1 | 8.6 | GO:0045176 | apical protein localization(GO:0045176) |
1.1 | 1.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.1 | 7.5 | GO:0097264 | self proteolysis(GO:0097264) |
1.1 | 3.2 | GO:0030070 | insulin processing(GO:0030070) |
1.1 | 2.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.0 | 1.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.0 | 16.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
1.0 | 3.1 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.0 | 10.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.0 | 7.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.0 | 5.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.0 | 7.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.0 | 6.1 | GO:0008038 | neuron recognition(GO:0008038) |
1.0 | 14.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
1.0 | 4.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.0 | 18.0 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
1.0 | 7.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 33.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
1.0 | 2.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.0 | 4.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.9 | 2.8 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.9 | 68.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.9 | 2.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.9 | 1.8 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
0.9 | 7.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.9 | 2.7 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 1.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 2.7 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.9 | 26.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.9 | 10.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.9 | 0.9 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.9 | 6.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.9 | 1.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.9 | 2.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.9 | 4.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.9 | 2.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.9 | 0.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.9 | 5.3 | GO:0001964 | startle response(GO:0001964) |
0.9 | 10.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.9 | 2.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) formin-nucleated actin cable assembly(GO:0070649) |
0.9 | 75.0 | GO:0007612 | learning(GO:0007612) |
0.9 | 5.2 | GO:0007614 | short-term memory(GO:0007614) |
0.8 | 6.8 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.8 | 0.8 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.8 | 1.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.8 | 1.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 4.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.8 | 0.8 | GO:0021586 | pons maturation(GO:0021586) |
0.8 | 4.6 | GO:0030432 | peristalsis(GO:0030432) |
0.8 | 0.8 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.8 | 3.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.7 | 1.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.7 | 3.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 0.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.7 | 3.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.7 | 0.7 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.7 | 2.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.7 | 7.9 | GO:0007616 | long-term memory(GO:0007616) |
0.7 | 2.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.7 | 0.7 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.7 | 8.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 0.7 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.7 | 1.4 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.7 | 2.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.7 | 0.7 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 0.7 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.7 | 1.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.7 | 2.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.7 | 2.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.7 | 3.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.7 | 6.0 | GO:0046847 | filopodium assembly(GO:0046847) |
0.7 | 3.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.7 | 1.3 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.7 | 3.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.7 | 4.6 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.7 | 1.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.6 | 3.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.6 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 2.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 1.9 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.6 | 4.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.6 | 18.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.6 | 5.6 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.6 | 0.6 | GO:0032536 | regulation of cell projection size(GO:0032536) |
0.6 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 1.8 | GO:0071435 | potassium ion export(GO:0071435) |
0.6 | 2.4 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.6 | 1.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.6 | 1.8 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.6 | 4.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 1.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.6 | 5.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.6 | 0.6 | GO:0043134 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.6 | 1.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.6 | 1.7 | GO:0015808 | L-alanine transport(GO:0015808) |
0.6 | 2.2 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 1.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 12.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 5.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 2.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 2.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.5 | 2.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 1.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 4.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 1.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 3.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 3.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.5 | 2.1 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.5 | 1.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 1.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.5 | 2.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.5 | 1.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.5 | 1.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.5 | 2.0 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 8.8 | GO:0021766 | hippocampus development(GO:0021766) |
0.5 | 0.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.5 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 1.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.5 | 1.0 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.5 | 1.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 1.4 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.5 | 0.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 1.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 1.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.5 | 1.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 0.9 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 0.9 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.4 | 1.8 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.4 | 6.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 1.8 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.4 | 0.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.4 | 0.4 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.4 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.4 | 0.4 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.4 | 3.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 1.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 0.4 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
0.4 | 2.6 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 2.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.4 | 0.9 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 3.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 1.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.4 | 2.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 5.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.4 | 1.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 2.1 | GO:0015816 | glycine transport(GO:0015816) |
0.4 | 1.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 0.8 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.4 | 0.4 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.4 | 1.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 1.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.4 | 1.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 1.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.4 | 0.8 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.4 | 4.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 3.5 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.4 | 6.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 2.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.4 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 9.5 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.4 | 0.4 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.4 | 5.5 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.4 | 0.4 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 0.4 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.4 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 1.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 2.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.4 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 0.4 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.4 | 1.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 0.3 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.3 | 0.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 0.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 3.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 1.0 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 1.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 9.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 1.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 1.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 1.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 4.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 6.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 0.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 1.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.3 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.3 | 8.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.3 | GO:1903598 | angiotensin-mediated drinking behavior(GO:0003051) positive regulation of gap junction assembly(GO:1903598) |
0.3 | 2.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.3 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 4.9 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.3 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 1.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 2.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 0.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 1.8 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.3 | 0.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.9 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.3 | 3.5 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.3 | 0.3 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 0.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 0.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 2.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 0.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 | 1.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.3 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 2.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 1.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 1.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.3 | 7.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.3 | 0.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 2.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 17.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 0.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.3 | 0.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.3 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 0.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 0.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 1.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 4.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.3 | 0.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 15.3 | GO:0099531 | neurotransmitter secretion(GO:0007269) presynaptic process involved in chemical synaptic transmission(GO:0099531) signal release from synapse(GO:0099643) |
0.3 | 1.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 1.0 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 2.8 | GO:0032094 | response to food(GO:0032094) |
0.3 | 0.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.3 | 12.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 1.0 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 1.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 2.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.7 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.2 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.2 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.7 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 6.9 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 1.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 0.7 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 0.9 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 1.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 1.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 1.4 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.9 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.2 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.2 | 2.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 2.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.9 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 0.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 0.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.7 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 0.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 1.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 4.6 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.2 | 0.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.4 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 1.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 0.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.4 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 2.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 0.6 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 1.6 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.2 | 0.6 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 3.6 | GO:0021549 | cerebellum development(GO:0021549) |
0.2 | 0.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 1.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 1.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 1.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.9 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.2 | 0.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 2.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.7 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 1.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 1.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 1.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 0.2 | GO:0007632 | visual behavior(GO:0007632) |
0.2 | 4.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.7 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 6.1 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.2 | 1.2 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 2.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.2 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.2 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.2 | 0.2 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 0.3 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.2 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.5 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.3 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.2 | 1.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.3 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.2 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.6 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.6 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.2 | 0.3 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 0.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 1.1 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 1.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.2 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 1.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.2 | 1.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.2 | 0.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 0.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.6 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 1.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.4 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.1 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.1 | 7.2 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 1.0 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.4 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.5 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 1.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.5 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.1 | 0.8 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.4 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.7 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.5 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 2.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.5 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.1 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.6 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.1 | 0.2 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.5 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.6 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.1 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.1 | 0.2 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 3.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.3 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.6 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.1 | 0.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.6 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.8 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.5 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.4 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.9 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.7 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.4 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.1 | GO:0007418 | ventral midline development(GO:0007418) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 3.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.2 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 2.5 | GO:0050905 | neuromuscular process(GO:0050905) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.5 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.3 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 1.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 1.1 | GO:0097479 | synaptic vesicle localization(GO:0097479) |
0.1 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.6 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.1 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.3 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.1 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.3 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 2.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.2 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.1 | 0.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.1 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 6.4 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.5 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.1 | 0.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.6 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 1.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.9 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.4 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 0.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.2 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.1 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 1.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 1.7 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.0 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 0.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 1.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 1.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.0 | GO:0046755 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.1 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.0 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.0 | 0.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.0 | 0.0 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.0 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.0 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
3.9 | 19.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.3 | 26.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
2.4 | 19.3 | GO:0043083 | synaptic cleft(GO:0043083) |
2.4 | 45.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.3 | 16.0 | GO:0032584 | growth cone membrane(GO:0032584) |
2.1 | 21.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.1 | 6.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.0 | 17.8 | GO:0005883 | neurofilament(GO:0005883) |
1.9 | 5.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.9 | 13.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.7 | 12.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.7 | 8.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.7 | 16.5 | GO:0030673 | axolemma(GO:0030673) |
1.6 | 78.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.6 | 7.8 | GO:0097433 | dense body(GO:0097433) |
1.5 | 10.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.5 | 18.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.5 | 10.6 | GO:0097449 | astrocyte projection(GO:0097449) |
1.5 | 4.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.5 | 4.4 | GO:0072534 | perineuronal net(GO:0072534) |
1.4 | 47.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.4 | 36.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.4 | 5.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.3 | 37.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.2 | 7.4 | GO:0043194 | axon initial segment(GO:0043194) |
1.2 | 28.4 | GO:0044295 | axonal growth cone(GO:0044295) |
1.2 | 4.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.2 | 14.2 | GO:0031045 | dense core granule(GO:0031045) |
1.2 | 2.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.1 | 16.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.1 | 10.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.1 | 7.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.1 | 8.7 | GO:0071437 | invadopodium(GO:0071437) |
1.1 | 9.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 10.5 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.0 | 1.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.0 | 18.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.9 | 122.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.9 | 10.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.8 | 2.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.8 | 39.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.8 | 23.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.8 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 3.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.7 | 65.2 | GO:0030426 | growth cone(GO:0030426) |
0.7 | 4.4 | GO:0043203 | axon hillock(GO:0043203) |
0.7 | 2.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 4.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.7 | 3.9 | GO:0044292 | dendrite terminus(GO:0044292) |
0.6 | 1.3 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.6 | 1.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.6 | 1.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 5.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.6 | 1.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 4.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 0.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.5 | 5.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 6.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 0.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 23.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.5 | 1.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 36.7 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 3.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 1.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 0.8 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 3.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 2.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.4 | 1.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 4.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 2.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 4.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 1.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 11.4 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 17.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.3 | 1.0 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 44.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 3.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 6.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 0.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 0.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 0.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 6.3 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 15.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 3.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 2.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.6 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.0 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 1.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 1.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 5.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.5 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 2.3 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 23.2 | GO:0030424 | axon(GO:0030424) |
0.2 | 0.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 11.7 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.2 | 1.7 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 1.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 2.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 1.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.5 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.9 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 1.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 40.9 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.9 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.6 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.5 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.5 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 0.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.2 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.1 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 1.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.4 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 2.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.2 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 2.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 1.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.8 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 2.5 | GO:0097458 | neuron part(GO:0097458) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 2.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.5 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.8 | 32.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
6.0 | 11.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
5.3 | 26.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.7 | 18.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
4.6 | 13.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
4.2 | 12.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.2 | 38.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
3.2 | 22.2 | GO:0003680 | AT DNA binding(GO:0003680) |
2.8 | 11.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.7 | 16.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.5 | 12.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.5 | 14.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.3 | 18.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
2.2 | 19.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.1 | 15.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.1 | 8.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.0 | 6.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.0 | 5.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.9 | 36.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.9 | 15.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.8 | 5.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.7 | 8.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.7 | 8.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.6 | 4.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.6 | 11.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.6 | 6.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.6 | 7.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.6 | 4.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.6 | 3.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.5 | 4.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.5 | 6.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
1.4 | 5.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.4 | 4.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.3 | 4.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.3 | 6.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.3 | 1.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.3 | 6.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.2 | 8.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.2 | 4.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.2 | 2.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.2 | 6.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.2 | 9.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.2 | 2.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.1 | 17.2 | GO:0031402 | sodium ion binding(GO:0031402) |
1.1 | 3.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
1.1 | 12.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.1 | 6.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.1 | 3.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 5.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.0 | 11.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.0 | 2.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.0 | 23.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.0 | 9.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.0 | 4.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.0 | 4.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 19.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.0 | 4.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.9 | 9.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.9 | 4.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.9 | 12.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.9 | 4.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.9 | 6.3 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.9 | 4.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.9 | 11.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.9 | 4.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.8 | 6.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.8 | 3.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 3.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.8 | 5.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.8 | 19.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.8 | 3.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.8 | 5.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.8 | 0.8 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.8 | 8.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.8 | 5.3 | GO:0043495 | protein anchor(GO:0043495) |
0.8 | 2.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.7 | 2.8 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.7 | 12.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.7 | 2.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 19.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.7 | 24.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.7 | 4.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.7 | 7.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 16.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.7 | 1.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 4.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.7 | 2.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 2.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 2.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.7 | 0.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.7 | 5.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 8.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.6 | 1.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 14.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.6 | 1.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 2.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.6 | 2.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 2.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.6 | 1.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 1.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 2.3 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 1.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.6 | 4.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 6.6 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 0.5 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.5 | 3.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 2.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 4.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 15.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 34.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.5 | 1.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 3.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.5 | 8.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 10.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.5 | 3.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.5 | 8.0 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 8.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 0.5 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.5 | 9.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 1.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.5 | 1.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 1.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 7.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 1.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.5 | 1.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 9.6 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 0.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.5 | 6.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.5 | 2.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 0.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.5 | 2.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 1.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 12.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 3.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 10.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 3.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 4.7 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 0.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 6.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 10.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 1.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 0.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 1.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 0.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 1.5 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 1.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 4.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 0.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.4 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 3.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 1.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 8.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.4 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 1.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 0.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 1.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 2.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 2.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 0.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 2.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 1.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 8.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 0.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 8.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 3.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 8.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.3 | 1.2 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.3 | 0.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 0.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.3 | 0.9 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 6.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 2.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 6.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 2.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 1.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 13.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 1.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 0.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 2.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 1.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 2.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 0.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 2.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 3.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.7 | GO:0018542 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 3.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 4.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 10.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 5.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 1.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 1.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 3.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 2.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 2.5 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 2.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 2.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 1.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.6 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 8.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 4.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.6 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 1.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 0.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 0.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 3.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 3.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.8 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.9 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.4 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.2 | 1.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 3.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 3.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 30.9 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 2.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 0.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 2.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 3.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.4 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 0.3 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.4 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 2.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 1.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.5 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 4.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.5 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.5 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.5 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.5 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.8 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 12.3 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 2.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 5.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.7 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 3.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 1.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.8 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.0 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 1.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 1.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 4.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.2 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.0 | 0.4 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 1.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 8.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.3 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.4 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 31.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.9 | 12.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 0.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.6 | 14.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.6 | 15.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.6 | 17.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 6.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 11.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 19.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 16.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 23.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 4.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 4.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 15.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 6.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 3.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 1.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 3.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 1.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 4.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 11.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 5.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 3.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 10.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 2.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 1.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 2.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 2.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 31.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.1 | 19.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.1 | 22.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.0 | 2.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.9 | 15.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.9 | 7.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.8 | 40.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.7 | 25.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.7 | 23.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.6 | 26.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 27.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.2 | 12.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.2 | 3.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.1 | 8.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.1 | 17.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.0 | 14.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.0 | 19.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.0 | 3.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.0 | 6.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.9 | 5.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.9 | 9.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.9 | 12.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.8 | 15.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.8 | 18.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.8 | 18.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 34.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.7 | 32.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 5.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 15.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.7 | 7.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 9.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.6 | 8.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 6.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 8.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.5 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 8.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 7.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 3.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 1.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 5.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.4 | 7.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 1.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 8.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 7.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 6.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 11.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 1.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 10.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 6.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 2.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 5.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 0.8 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 2.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 2.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 1.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 3.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 4.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 25.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 1.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 5.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 1.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 4.4 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 2.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 2.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 3.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 3.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 4.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.9 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 2.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |